ACS Cancer Research Program rss


Ga-68 imaging changes clinical management of GI and pancreatic neuroendocrine tumors(0)

July 21, 2020

Ga-68 positron emission tomography has improved the clinical management of gastrointestinal and pancreatic neuroendocrine tumors, and multiple studies are ongoing to define its optimal role in clinical practice.



Early-stage prostate cancer decision aids for diverse patient populations

The aim of the Alliance A191402CD trial is to evaluate the use of decision aids for men choosing treatment for located prostate cancer, particularly in minority populations.

ACS Clinical Research Program

What is the National Clinical Trials Network, and how do I join?

A summary of the structure and function of the National Cancer Institute’s National Clinical Trial Network is provided.


ACS Clinical Research Program sessions at Clinical Congress 2019: A recap

A summary of the ACS Clinical Research Program sessions at Clinical Congress 2019 is provided.


Modified FOLFIRINOX is superior to gemcitabine as adjuvant therapy for resected pancreatic cancer: The PRODIGE 24/CCTG PA6 Trial

The study design and findings of the PRODIGE 24/CCTG PA6 Trial are outlined, which showed improved survival with modified FOLFIRINOX for resected pancreatic cancer patients.

More in this category

« Older Posts   


Bulletin of the American College of Surgeons
633 N. Saint Clair St.
Chicago, IL 60611


Download the Bulletin App

Apple Store
Get it on Google Play
Amazon store